epigallocatechin gallate has been researched along with Atherogenesis in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (31.82) | 29.6817 |
| 2010's | 13 (59.09) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Yamagata, K | 1 |
| Chen, W; Feng, X; Li, L; Xu, S; Zhang, L; Zhang, S | 1 |
| Ahsan, A; Chu, P; Han, G; Li, H; Lin, Y; Liu, S; Peng, J; Sun, B; Sun, Z; Tang, Z; Wu, J; Xi, Y; Zhang, Z; Zhou, Z | 1 |
| Abbasi, M; Brackee, G; Cao, J; Labib, S; Li, C; Nie, S; Shen, CL; Wang, S; Wu, D; Zhang, J; Zu, Y | 1 |
| Cai, Y; Hashizume, T; Kurita-Ochiai, T; Yamamoto, M | 1 |
| Ahmed, S; Kaplan, MJ; Riegsecker, S; Wiczynski, D | 1 |
| Nie, S; Wang, S; Zhang, J | 1 |
| Pan, J; Xu, X; Zhou, X | 1 |
| Chong, IW; Hsieh, CC; Kuo, HF; Liu, JT; Liu, PL | 1 |
| Du, Q; Hong, Z; Jiang, Y; Jin, J; Xu, Y; Yin, JF | 1 |
| Huang, F; Peng, D; Yi, Y; Yin, J; Yin, L | 1 |
| Martinez-Zaguilan, R; Nie, S; Sennoune, SR; Wang, S; Zhang, J | 1 |
| Ishizaki, Y; Kikuzaki, H; Kobayashi, K; Kojo, S | 1 |
| Arulmathi, K; Kalaiselvi, P; Senthil Kumaran, V; Sundarapandiyan, R | 1 |
| Jackson, KG; Minihane, AM; Moore, RJ | 1 |
| Geraldine, P; Ramesh, E; Thomas, PA | 1 |
| da Silva, EL; Hort, MA; Maraschin, M; Minatti, J; Ribeiro-do-Valle, RM; Wazlawik, E; Zaleski, FL | 1 |
| Anglard, P; El Bedoui, J; Oak, MH; Schini-Kerth, VB | 1 |
| Cheng, TO | 1 |
| Ivanov, V; Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
| Shenouda, SM; Vita, JA | 1 |
| Elanchezhian, R; Geraldine, P; Jayakumar, T; Ramesh, E; Sakthivel, M; Senthil Kumar, RS; Thomas, PA | 1 |
6 review(s) available for epigallocatechin gallate and Atherogenesis
| Article | Year |
|---|---|
Protective Effect of Epigallocatechin Gallate on Endothelial Disorders in Atherosclerosis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Atherosclerosis; Catechin; Cell Adhesion Molecules; Endothelial Cells; Endothelin-1; Endothelium, Vascular; Humans; Nitric Oxide; Oxidative Stress | 2020 |
Natural products: The role and mechanism in low-density lipoprotein oxidation and atherosclerosis.
Topics: Abietanes; Antioxidants; Atherosclerosis; Biological Products; Catechin; Dietary Supplements; Humans; Lipoproteins, LDL; Lycopene; Phytotherapy; Plant Extracts; Probucol; Quercetin; Resveratrol; Vitamin E | 2021 |
Potential benefits of green tea polyphenol EGCG in the prevention and treatment of vascular inflammation in rheumatoid arthritis.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Atherosclerosis; Catechin; Complementary Therapies; Cytokines; Humans; Inflammation; Tea | 2013 |
Green tea (Camellia sinensis) catechins and vascular function.
Topics: Animals; Atherosclerosis; Biological Availability; Blood Vessels; Camellia sinensis; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Catechin; Endothelium, Vascular; Flavonoids; Homeostasis; Humans; Phenols; Phytotherapy; Polyphenols; Signal Transduction; Tea | 2009 |
All teas are not created equal: the Chinese green tea and cardiovascular health.
Topics: Animals; Antioxidants; Atherosclerosis; Cardiovascular Diseases; Cardiovascular System; Catechin; Diabetes Mellitus; Endothelium, Vascular; Humans; Metabolic Syndrome; Obesity; Phytotherapy; Plant Extracts; Tea | 2006 |
Effects of flavonoid-containing beverages and EGCG on endothelial function.
Topics: Antioxidants; Atherosclerosis; Beverages; Cardiovascular Diseases; Catechin; Endothelium, Vascular; Flavonoids; Humans; Risk Factors | 2007 |
16 other study(ies) available for epigallocatechin gallate and Atherogenesis
| Article | Year |
|---|---|
EGCG protects against homocysteine-induced human umbilical vein endothelial cells apoptosis by modulating mitochondrial-dependent apoptotic signaling and PI3K/Akt/eNOS signaling pathways.
Topics: Antioxidants; Apoptosis; Atherosclerosis; Catechin; Homocysteine; Human Umbilical Vein Endothelial Cells; Humans; Hyperhomocysteinemia; Mitochondria; Nitric Oxide Synthase Type III; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Signal Transduction | 2017 |
Anti-atherogenic effects of CD36-targeted epigallocatechin gallate-loaded nanoparticles.
Topics: Animals; Atherosclerosis; Catechin; CD36 Antigens; Cells, Cultured; Liver; Macrophages, Peritoneal; Male; Mice, Inbred C57BL; Mice, Knockout; Nanoparticles; Receptors, LDL; RNA, Small Interfering | 2019 |
Green tea epigallocatechin-3-gallate attenuates Porphyromonas gingivalis-induced atherosclerosis.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Atherosclerosis; Bacteroidaceae Infections; Biomarkers; Catechin; Disease Models, Animal; Gene Expression Profiling; Male; Mice; Mice, Knockout; Porphyromonas gingivalis; Tea Tree Oil; Treatment Outcome | 2013 |
Nanoencapsulation enhances epigallocatechin-3-gallate stability and its antiatherogenic bioactivities in macrophages.
Topics: Atherosclerosis; Camellia sinensis; Cardiovascular Agents; Catechin; Cell Line; Chemokine CCL2; Cholesterol; Drug Compounding; Drug Stability; Humans; Macrophages; Nanoparticles; Plant Extracts | 2013 |
Amelioration of lipid profile and level of antioxidant activities by epigallocatechin-gallate in a rat model of atherogenesis.
Topics: Animals; Antioxidants; Atherosclerosis; Catechin; Diet, Atherogenic; Disease Models, Animal; Lipids; Male; Rats; Rats, Wistar | 2014 |
Epigallocatechin gallate attenuates proliferation and oxidative stress in human vascular smooth muscle cells induced by interleukin-1β via heme oxygenase-1.
Topics: Antioxidants; Atherosclerosis; Catechin; Cell Proliferation; Cells, Cultured; Enzyme Induction; Heme Oxygenase-1; Humans; Interleukin-1beta; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-E2-Related Factor 2; Oxidative Stress | 2014 |
Improving the effectiveness of (-)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic acid.
Topics: Animals; Atherosclerosis; Biological Availability; Catechin; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Delivery Systems; Humans; Male; Nanoparticles; Particle Size; Peptides; Rabbits | 2014 |
EGCG attenuates atherosclerosis through the Jagged-1/Notch pathway.
Topics: Animals; Apolipoproteins E; Apoptosis; Atherosclerosis; Calcium-Binding Proteins; Catechin; Gene Expression Regulation, Enzymologic; Human Umbilical Vein Endothelial Cells; Humans; Intercellular Signaling Peptides and Proteins; Jagged-1 Protein; Lipoproteins, LDL; Membrane Proteins; Mice; Mice, Knockout; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Receptors, Notch; Serrate-Jagged Proteins; Signal Transduction | 2016 |
Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles.
Topics: Atherosclerosis; Catechin; CD36 Antigens; Humans; Nanoparticles | 2016 |
Strong Inhibition of Secretory Sphingomyelinase by Catechins, Particularly by (-)-Epicatechin 3-O-Gallate and (-)-3'-O-Methylepigallocatechin 3-O-Gallate.
Topics: Animals; Atherosclerosis; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Hydrogen-Ion Concentration; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sphingomyelin Phosphodiesterase | 2016 |
Attenuation of the inflammatory changes and lipid anomalies by epigallocatechin-3-gallate in hypercholesterolemic diet fed aged rats.
Topics: Aging; Animals; Antioxidants; Atherosclerosis; Biomarkers; Catechin; Diet, Atherogenic; Hypercholesterolemia; Inflammation; Lipids; Male; Rats; Rats, Wistar | 2009 |
Regulatory effect of epigallocatechin gallate on the expression of C-reactive protein and other inflammatory markers in an experimental model of atherosclerosis.
Topics: Animals; Aorta, Thoracic; Atherosclerosis; Biomarkers; Blood Sedimentation; C-Reactive Protein; Catechin; Diet, Atherogenic; Disease Models, Animal; Inflammation; Injections, Intraperitoneal; Lymphocyte Count; Male; Platelet Count; Rats; Rats, Wistar | 2010 |
Green tea extract reverses endothelial dysfunction and reduces atherosclerosis progression in homozygous knockout low-density lipoprotein receptor mice.
Topics: Alanine Transaminase; Animals; Antioxidants; Aorta; Atherosclerosis; Biomarkers; Catechin; Chemokine CCL2; Disease Models, Animal; Endothelium, Vascular; Female; Inflammation; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Plant Extracts; Receptors, LDL; Tea; Triglycerides; Tumor Necrosis Factor-alpha | 2012 |
Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression.
Topics: Aorta; Atherosclerosis; Blotting, Northern; Blotting, Western; Catechin; Cell Movement; Cells, Cultured; Gene Expression; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Muscle, Smooth, Vascular; Neoplasms; Tea; Thrombin | 2005 |
Anti-atherogenic effects of a mixture of ascorbic acid, lysine, proline, arginine, cysteine, and green tea phenolics in human aortic smooth muscle cells.
Topics: Amino Acids; Animals; Aorta; Ascorbic Acid; Atherosclerosis; Catechin; Cattle; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Dose-Response Relationship, Drug; Humans; Immunochemistry; Interleukin-6; Matrix Metalloproteinase 2; Myocytes, Smooth Muscle; Phenols; Plant Extracts; Tea | 2007 |
Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet.
Topics: Animals; Anticholesteremic Agents; Antioxidants; Aorta, Thoracic; Ascorbic Acid; Atherosclerosis; Camellia sinensis; Catalase; Catechin; Diet, Atherogenic; Erythrocytes; Glutathione Peroxidase; Hypercholesterolemia; Injections, Intraperitoneal; Lipid Peroxidation; Lipids; Male; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; Superoxide Dismutase; Vitamin E | 2008 |